Daiwa Securities Group
SLS icon

Daiwa Securities Group’s SELLAS Life Sciences SLS Stock Holding History

Daiwa Securities Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
102,500
+100,300
+4,559% +$692K ﹤0.01% 748
2026
Q1 		$9.31K Buy
+2,200
New +$9.84K ﹤0.01% 1143

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Daiwa Securities Group's SLS Position: Q2 2026 in Review

Daiwa Securities Group increased its SELLAS Life Sciences (SLS) stake by 4,559% in Q2 2026, buying an estimated $692K and bringing the position to 102,500 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #748.

Daiwa Securities Group first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Daiwa Securities Group held 102,500 shares of SELLAS Life Sciences worth $1.51M as of Q2 2026.
  • Daiwa Securities Group bought 100,300 SELLAS Life Sciences shares in Q2 2026, an estimated $692K.
  • SELLAS Life Sciences made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #748 holding.
  • Daiwa Securities Group first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.